{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:57:13Z","timestamp":1789419433033,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cytoreductive surgery (CRS) for peritoneal metastases of colorectal cancer (PMCRC) is associated with a high risk of postoperative morbidity, thus making patient selection of upmost importance. Further to data showing an association between preoperative serological biomarkers and patient outcome in various solid tumors, in this study we aim to evaluate their prognostic value in patients with PMCRC treated with curative intent.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and Methods<\/jats:title>\n                <jats:p>This is a retrospective study including patients with PMCRC treated by complete CRS \u00b1 HIPEC at our institution between 2011 and 2020. Preoperative serological biomarkers, along with other standard clinicopathological variables, were studied to determine their prognostic value.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 94 out of 108 patients met the inclusion criteria. Forty-three patients (46%) presented with synchronous PM. The median peritoneal cancer index (PCI) was 6. On univariate analysis, a higher neutrophil-to-lymphocyte ratio (NLR) was associated with poor prognosis in terms of overall survival (OS) [cutoff 3.567, hazard ratio (HR) 2.8 (1.4\u20135.3), <jats:italic>p<\/jats:italic> = 0.002], whereas a higher platelet-to-lymphocyte ratio (PLR) predicted favorable prognosis in terms of disease-free survival (DFS) [cutoff 185.4, HR 1.9 (1.07\u20133.53), <jats:italic>p<\/jats:italic> = 0.030]. On multivariate analysis, NLR &gt; 3.567, positive lymph nodes (LNs), and PCI &gt; 7 were independent predictive factors for worse OS, whereas NLR &gt; 3.567 and positive LNs were significantly associated with worse DFS. PLR &gt; 185.4 was associated with better DFS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>High preoperative NLR (&gt; 3.567) and PLR (&gt; 185.4) can predict outcome of patients with PMCRC treated by complete CRS \u00b1 HIPEC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-022-12736-1","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:03:10Z","timestamp":1668009790000},"page":"1863-1869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-4616","authenticated-orcid":false,"given":"Antoine","family":"El Asmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel","family":"Kamden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charif","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bohlok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sclafani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Donckier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"12","key":"12736_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/J.1365-2168.2002.02274.X","volume":"89","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545\u201350. https:\/\/doi.org\/10.1046\/J.1365-2168.2002.02274.X.","journal-title":"Br J Surg."},{"issue":"11","key":"12736_CR2","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/IJC.25596","volume":"128","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128(11):2717\u201325. https:\/\/doi.org\/10.1002\/IJC.25596.","journal-title":"Int J Cancer."},{"issue":"3","key":"12736_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/S11888-013-0173-6\/TABLES\/2","volume":"9","author":"J Franko","year":"2013","unstructured":"Franko J, Goldman CD, Turaga KK. Role of chemotherapy in peritoneal carcinomatosis in metastatic colorectal cancer. Curr Colorectal Cancer Rep. 2013;9(3):242\u20139. https:\/\/doi.org\/10.1007\/S11888-013-0173-6\/TABLES\/2.","journal-title":"Curr Colorectal Cancer Rep."},{"issue":"5","key":"12736_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/SLA.0B013E3181D9765D","volume":"251","author":"D Elias","year":"2010","unstructured":"Elias D, Glehen O, Pocard M, et al. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg. 2010;251(5):896\u2013901. https:\/\/doi.org\/10.1097\/SLA.0B013E3181D9765D.","journal-title":"Ann Surg."},{"issue":"2","key":"12736_CR5","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/J.EJSO.2018.10.086","volume":"45","author":"F Quenet","year":"2019","unstructured":"Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. PRODIGE 7. Eur J Surg Oncol. 2019;45(2):e17. https:\/\/doi.org\/10.1016\/J.EJSO.2018.10.086.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"12736_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/00015458.2019.1610260","volume":"119","author":"G Liberale","year":"2019","unstructured":"Liberale G, Ameye L, Hendlisz A. PRODIGE 7 should be interpreted with caution. Acta Chir Belg. 2019;119(4):263\u20136. https:\/\/doi.org\/10.1080\/00015458.2019.1610260.","journal-title":"Acta Chir Belg."},{"issue":"5","key":"12736_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/02656736.2017.1367846","volume":"34","author":"M Alyami","year":"2017","unstructured":"Alyami M, Kim BJ, Villeneuve L, et al. Ninety-day post-operative morbidity and mortality using the National Cancer Institute\u2019s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperth. 2017;34(5):532\u20137. https:\/\/doi.org\/10.1080\/02656736.2017.1367846.","journal-title":"Int J Hyperth."},{"key":"12736_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2009","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2009;28:63\u20138. https:\/\/doi.org\/10.1200\/JCO.2009.23.9285.","journal-title":"J Clin Oncol."},{"issue":"6","key":"12736_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/SLA.0000000000001618","volume":"264","author":"G Liberale","year":"2016","unstructured":"Liberale G, Vankerckhove S, Gomez Caldon M, et al. Fluorescence imaging after indocyanine green injection for detection of peritoneal metastases in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from colorectal cancer: a pilot study. Ann Surg. 2016;264(6):1110\u20135. https:\/\/doi.org\/10.1097\/SLA.0000000000001618.","journal-title":"Ann Surg."},{"issue":"9","key":"12736_CR10","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/S10434-015-4387-5\/TABLES\/3","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22(9):2958\u201364. https:\/\/doi.org\/10.1245\/S10434-015-4387-5\/TABLES\/3.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"12736_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0143080","volume":"10","author":"S Shrotriya","year":"2015","unstructured":"Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review. PLoS One. 2015;10(12):e0143080. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0143080.","journal-title":"PLoS One."},{"issue":"1","key":"12736_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-020-02081-6","volume":"18","author":"A El Asmar","year":"2020","unstructured":"El Asmar A, Bendavides M, Moreau M, et al. Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. World J Surg Oncol. 2020;18(1):1\u20137. https:\/\/doi.org\/10.1186\/s12957-020-02081-6.","journal-title":"World J Surg Oncol."},{"issue":"1","key":"12736_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1207\/S15327914NC3701_4","volume":"37","author":"P O\u2019Gorman","year":"2009","unstructured":"O\u2019Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer. 2009;37(1):36\u201340. https:\/\/doi.org\/10.1207\/S15327914NC3701_4.","journal-title":"Nutr Cancer"},{"issue":"2","key":"12736_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1207\/S15327914NC352_5","volume":"35","author":"P O\u2019Gorman","year":"2009","unstructured":"O\u2019Gorman P, McMillan DC, McArdle CS. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr cancer. 2009;35(2):127\u20139. https:\/\/doi.org\/10.1207\/S15327914NC352_5.","journal-title":"Nutr cancer"},{"issue":"7","key":"12736_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1158\/1055-9965.EPI-14-0146","volume":"23","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1204\u201312. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0146.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"12736_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/JNCI\/DJU124","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI J Natl Cancer Inst. 2014. https:\/\/doi.org\/10.1093\/JNCI\/DJU124.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"18","key":"12736_CR17","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.7150\/JCA.46446","volume":"11","author":"Q Yan","year":"2020","unstructured":"Yan Q, Ertao Z, Zhimei Z, et al. Systemic immune-inflammation index (SII): a more promising inflammation-based prognostic marker for patients with synchronic colorectal peritoneal carcinomatosis. J Cancer. 2020;11(18):5264. https:\/\/doi.org\/10.7150\/JCA.46446.","journal-title":"J Cancer."},{"key":"12736_CR18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4096-5","author":"FJ Medina Fern\u00e1ndez","year":"2015","unstructured":"Medina Fern\u00e1ndez FJ, Mu\u00f1 Oz-Casares FC, Arjona-S\u00e1nchez A, et al. Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC. Ann Surg Oncol. 2015. https:\/\/doi.org\/10.1245\/s10434-014-4096-5.","journal-title":"Ann Surg Oncol."},{"key":"12736_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/J.SURONC.2020.09.002","volume":"35","author":"Y Zager","year":"2020","unstructured":"Zager Y, Hoffman A, Dreznik Y, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: the prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. Surg Oncol. 2020;35:321\u20137. https:\/\/doi.org\/10.1016\/J.SURONC.2020.09.002.","journal-title":"Surg Oncol."},{"key":"12736_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11605-021-05218-4","volume":"0123456789","author":"A El Asmar","year":"2022","unstructured":"El Asmar A, Vouche M, Galdon MG, et al. Deep epigastric lymph nodes implication in patients\u2019 recurrence pattern after cytoreductive surgery in colorectal peritoneal metastases. J Gastrointest Surg. 2022;0123456789:1\u20134. https:\/\/doi.org\/10.1007\/s11605-021-05218-4.","journal-title":"J Gastrointest Surg."},{"issue":"1","key":"12736_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jso.26269","volume":"123","author":"A El Asmar","year":"2021","unstructured":"El Asmar A, Veys I, Larsimont D, Donckier V, Liberale G. Inferior epigastric artery lymph nodes: a pathway for systemic dissemination from peritoneal carcinomatosis? J Surg Oncol. 2021;123(1):311\u20134. https:\/\/doi.org\/10.1002\/jso.26269.","journal-title":"J Surg Oncol."},{"issue":"6","key":"12736_CR22","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/J.GASTRO.2010.01.058","volume":"138","author":"J Terzi\u0107","year":"2010","unstructured":"Terzi\u0107 J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology. 2010;138(6):2101-2114.e5. https:\/\/doi.org\/10.1053\/J.GASTRO.2010.01.058.","journal-title":"Gastroenterology."},{"key":"12736_CR23","unstructured":"Sgambato A. Inflammation and cancer: a multifaceted link immune checkpoint molecules view project. https:\/\/www.researchgate.net\/publication\/44624616. Accessed March 11, 2022."},{"key":"12736_CR24","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-33843\/v1","author":"A El Asmar","year":"2020","unstructured":"El Asmar A, Ghabi E, Saber T, Abou-Malhab C, Akl B, El Rassi Z. Platelet to lymphocyte ratio is correlated with a delay in feeding resumption following a transhiatal esophagectomy with cervical anastomosis. World J Surg Oncol. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-33843\/v1.","journal-title":"World J Surg Oncol."},{"issue":"1","key":"12736_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/bjc.2011.189","volume":"105","author":"MJM Gooden","year":"2011","unstructured":"Gooden MJM, De Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105(1):93\u2013103. https:\/\/doi.org\/10.1038\/bjc.2011.189.","journal-title":"Br J Cancer."},{"issue":"5","key":"12736_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/02656736.2017.1384073","volume":"34","author":"K Rangarajan","year":"2018","unstructured":"Rangarajan K, Chandrakumaran K, Dayal S, Mohamed F, Moran BJ, Cecil TD. The pre-operative neutrophil\u2013lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin. Int J Hyperth. 2018;34(5):559\u201363. https:\/\/doi.org\/10.1080\/02656736.2017.1384073.","journal-title":"Int J Hyperth."},{"issue":"49","key":"12736_CR27","doi-asserted-by":"publisher","first-page":"81849","DOI":"10.18632\/ONCOTARGET.13248","volume":"7","author":"Y Long","year":"2016","unstructured":"Long Y, Wang T, Gao Q, Zhou C. Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis. Oncotarget. 2016;7(49):81849. https:\/\/doi.org\/10.18632\/ONCOTARGET.13248.","journal-title":"Oncotarget."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12736-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T21:33:02Z","timestamp":1675891982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12736-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12736"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12736-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interest. No funding was received for this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}